BAX Baxter International Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
20:51
Aug 03
Aug 03
Medical devices (IHI, MDT, ABT, BAX) outperforming.
Healthcare/medical devices are showing relative strength improvement as funds reduce tech weight. IHI, Medtronic, Abbott, and Baxter have started outperforming in the last month and a half and should continue.
MED
11:40
Jul 31
Jul 31
Citigroup upgrades Baxter to Neutral, KBW upgrades Core Scientific and cuts Blackstone Mortgage.
Citigroup upgrades Baxter to Neutral, KBW upgrades Core Scientific and cuts Blackstone Mortgage, JP Morgan upgrades Patterson-UTI, H.C. Wainwright upgrades Karyopharm, Benchmark downgrades Roblox to Sell, and Stephens adjusts NBT Bancorp rating.
12:30
Jul 30
Jul 30
Management's tone is confident and forward-looking, citing broad-based growth across all segments, double-digit growth in drug compounding, and continued progress on strategic priorities like cash flow and leverage reduction. The reiterated guidance for margin expansion in the second half and confidence in 2027 growth underpins the 'long' signal.
HIGH
14:00
Jul 14
Jul 14
Healthcare sector rotation for midterms.
Healthcare is set to dramatically outperform. The sector has fallen from 16-17% of the S&P 500 to just 8%, and a rotation is underway as midterm election dynamics favor Democrats and fiscal hawks. The firm has gone long healthcare, highlighting Intuitive Surgical and Baxter.
MED
20:30
Apr 30
Apr 30
The statement references Baxter as the prior employer of the incoming CFO Aaron Bloomer, providing historical context on his background but containing no forward-looking signal about Baxter's business.
HIGH
12:30
Apr 30
Apr 30
Guidance reiterated with flat organic growth, but management flags significant headwinds (Novum hold, tariffs, supply constraints) persisting through H1, with improvement expected only in H2. The flat tone and reiterated guidance indicate a neutral-to-cautious outlook.
HIGH
12:25
Apr 29
Apr 29
The tweet suggests portfolio managers have built careers betting against Jay Saccaro's.
The tweet suggests portfolio managers have built careers betting against Jay Saccaro's leadership at GE HealthCare and Baxter, implying a bearish outlook on both stocks.
HIGH
13:30
Feb 12
Feb 12
Management's 2026 outlook is conservative, with flat organic growth, operating margin pressure, and a back-half-weighted earnings cadence, reflecting ongoing challenges with the Novum pump hold, IV solutions rebasing, and pharma softness.
HIGH
About BAX Investor Commentary
Across the available history and selected sources, Buzzberg tracks BAX (Baxter International) across 5 sources: 2 bullish vs 0 bearish calls from 8 authors. Historical directional balance: 25% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 8 total trade ideas tracked. Latest voices: David Nicoski, DeItaone, Andrew Hider.